professionalIMG

Matthew W. Tikonoff

Associate vCard


Education

  • Suffolk University Law School (JD, magna cum laude)
  • Boston College (BA)

Bar Admissions

  • Massachusetts

Matt represents public and private companies and private equity firms in a broad range of transactions and corporate matters.  His practice focuses primarily on mergers and acquisitions, capital markets transactions, securities law compliance and general corporate representation.  Matt has served as counsel for clients in a number of sectors, including life sciences, telecommunications, retail, technology and higher education.

Before joining Mintz Levin, Matt was an associate at an international law firm. During law school, he served as Articles Editor of the Suffolk University Law Review.

Representative Matters

Mergers & Acquisitions

    • Philips Healthcare in connection with numerous middle-market mergers and acquisitions and other strategic transactions
    • Associated Home Care, a private-duty home health aide provider, in its sale to Amedisys (NASDAQ: AMED)
    • Netsmart Technologies, a health information technology provider, in its acquisitions of Lavender & Wyatt Systems and Trend Consulting Services
    • Frazier Healthcare Ventures, a middle-market private equity firm, in its acquisition of a medical footware company
    • SiOnyx, a semiconductor process company, in its acquisition by a leading private equity firm 
    • Edgile, a cybersecurity consulting firm, in a minority investment transaction with a leading private equity firm 
    • A privately-held distributor of industrial supplies in its sale to a strategic competitor
    • Essilor International, an eyewear company, in its acquisition of Costa (NASDAQ: ATX)
    • FGX International, an eyewear company, in its acquisition of Stylemark
    • Dynasil Corporation of America (NASDAQ: DYSL) in the sale of its cancer medical probe business to Dilon Technologies and the sale of its x-ray fluorescence lead paint detector business to Protec
    • PTC (NASDAQ: PTC) in its acquisition of Enigma Information Systems
    • Ampersand Capital Partners in its acquisitions of numerous portfolio companies

Securities Offerings

    • WAVE Life Sciences (NASDAQ: WVE) in its $102 million initial public offering
    • Stemline Therapeutics (NASDAQ: STML) in its $30 million initial public offering
    • Lamar Advertising Company (NASDAQ: LAMR) in Rule 144A debt offerings and follow-on exchange offers